Public-registry site landscape for NCT07716865, a Hereditary Cystatin C Amyloid Angiopathy (HCCAA) study sponsored by Arctic Therapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07716865 (registry record) |
| Sponsor | Arctic Therapeutics |
| Condition(s) | Hereditary Cystatin C Amyloid Angiopathy (HCCAA); Hemorrhage Brain; Hemorrhage Cerebral |
| Phase | PHASE2 |
| Listed sites | 1 |
| Site countries | Iceland |
Eichor generates a preliminary site-risk snapshot for NCT07716865 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →